Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Ethyl phosphonate" patented technology

Axitinib sustained-release implplant treating for solid tumor

The invention relates to an Axitinib sustained-release implant for treating a solid tumor, which is characterized in that: the sustained-release implant contains an effective anticancer amount of Axitinib and sustained-release excipients and a certain amount of sustained-release regulator. The solid tumors include the liver cancer, the lung cancer, the esophageal canner, the gastric canner, the breast canner, the ovarian canner, the prostate canner, the bladder canner and the rectum canner. The sustained-release excipients are mainly a copolymer of polylactic acid, glycollic acid and hydroxyacetic acid and one of the three materials, polifeprosan, poly-(L-lactide-co-ethyl phosphonate) and Poly(L-lactide-co-propyl phosphonate) or a combination of the three materials, in the degradation and absorption process of which the Axitinib is sustainedly released to part of the tumor, thus the entire toxicity of the Axitinib is significantly reduced while an effective medicine consistency is maintained on part of the tumor. That the sustained-release implant is implanted inside part of the tumor can not only reduce the entire toxicity of the Axitinib, but also enhance the medicine consistency on part of the tumor, thereby increasing the curing effect of non-operative therapeutics such as chemotherapeutic drugs and radiotherapy.
Owner:JINAN SHUAIHUA PHARMA TECH

Combustible cartridge case/box slurry formula and preparation method of combustible cartridge case/box

The invention provides a combustible cartridge case/box slurry formula and a preparation method of a combustible cartridge case/box. The formula comprises 100 parts of acrylic resin, 1-4 parts of a photoinitiator, 40-100 parts of a reactive diluent and 100-246 parts of explosive crystals, wherein the explosive crystals are one or a mixture of 1, 3, 5-trinitro-1, 3, 5-triazacyclohexane and 1, 3, 5, 7-tetranitro-1, 3, 5, 7-tetraazacyclooctane, the acrylic resin is epoxy acrylic resin, polyurethane acrylic resin or a mixture of the epoxy acrylic resin and the polyurethane acrylic resin, the photoinitiator is one or a mixture of 2, 4, 6-trimethylbenzoyl phenyl phosphonic acid ethyl ester and 4, 6-trimethylbenzoyl-diphenyl phosphine oxide, and the reactive diluent is one or a mixture of 2-(2-ethyoxyl ethyoxyl) ethyl acrylate and trimethylolpropane triacrylate. The formula provided by the invention can be used for 3D printing preparation. The powder force of the prepared combustible cartridge case/box reaches 845 J/g, the 5s explosion point is 356.6 DEG C, the spontaneous combustion resistance temperature at the temperature of 245 DEG C is larger than 300 s, and the hygroscopicity under the conditions that the temperature is 25 DEG C and the relative humidity is 89% is 0.5%.
Owner:XIAN MODERN CHEM RES INST

Production method for medicine for preventing and treating verticillium dahliae

The invention discloses a production method for a medicine for preventing and treating verticillium dahliae. The production method comprises the following steps: A preparing materials including 50% copper(succinate+glutarate+adipate), 60% aluminum tris(-O-ethyl phosphonate), 86.2% cuprous oxide wettable powder, artemisinin, pulsatilla chinensis saponin, glycyrrhizic acid, Shuanghuanglian and pericarpium citri reticulatae; B carrying out alcohol digestion on an extracting solution of the Shuanghuanglian and the pericarpium citri reticulatae; C compounding the 50% copper(succinate+glutarate+adipate), the 60% aluminum tris(-O-ethyl phosphonate), the 86.2% cuprous oxide wettable powder, the artemisinin, the pulsatilla chinensis saponin and the glycyrrhizic acid with the extracting solution obtained in the step B; and agitating uniformly and carrying out ultraviolet sterilization to obtain the medicine for preventing and treating the verticillium dahliae. The production method is simple and the produced medicine is easy in proportioning and convenient to use, and has the good effect of treating eggplant verticillium; tests prove that a 400-600-time diluting solution of the mixture has an obvious inactivation effect on te fungi imperfecti verticillium dahliae and the sterilizing effect is good.
Owner:QINGDAO MAOFENG ORGANIC VEGETABLE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products